Why Deck 7

January 1, 2020

With over 2,800 campaigns each year delivered through a team of 300+ digital, data, and technology specialists, Deck 7 is a first resource for B2B demand generation services for marketers worldwide.

Clients leverage Deck 7’s multichannel content marketing services and Media 7’s network of 30+ online publications for content syndication to engage over 95 million buyers across 16 industries and 120+ countries.

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

OTHER WHITEPAPERS
news image

Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers

whitePaper | January 10, 2023

The ideal care model for complex patients is a model in which the entire health care team is made up of experts in the specific disease state being treated. Integrated health care systems and major academic medical centers provide this level of expertise and coordination.

Read More
news image

Achieving diversity, equity and inclusion in clinical trials

whitePaper | April 26, 2022

The prevalence of communicable and non-communicable diseases are increasing worldwide, placing considerable demand on public health systems and driving a necessity to develop more effective targeted therapies.

Read More
news image

Transforming Patient Journey in Clinical Trials

whitePaper | April 7, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way.

Read More
news image

QbD and PAT in Biopharmaceutical Development

whitePaper | July 12, 2022

As the pharmaceutical industry tries to embrace the methodologies of quality by design (QbD) provided by the FDA ’s process validation (PV) guidance (1) and International Conference on Harmonization.

Read More
news image

Asia Pacific – Clinical trial landscape

whitePaper | November 8, 2022

The Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions.

Read More
news image

Understanding Net Pharmaceutical Expenditure Dynamics in Europe

whitePaper | April 12, 2022

The level of pharmaceutical expenditure is closely watched and often commented upon, but the composition of that expenditure and its dynamics are not as well understood.

Read More

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

Events